Hémato-oncologie

Voici la liste des publications récentes des professeurs du service d'hémato-oncologie du Département de médecine. Les cliniciens et les professeurs-chercheurs avec octrois de ce service sont en caractères gras. Les professeurs associés à ce service sont en italique.

Dernière mise à jour : 11 jan 2021

2019

1.      Attal, Michel, Paul G. Richardson, S. Vincent Rajkumar, Jesus San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Pavic M et al. « Isatuximab plus Pomalidomide and Low-Dose Dexamethasone versus Pomalidomide and Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma (ICARIA-MM): A Randomised, Multicentre, Open-Label, Phase 3 Study ». Lancet (London, England) 394, no 10214 (7 décembre 2019): 2096‑2107. https://doi.org/10.1016/S0140-6736(19)32556-5.

2.      Couture, Félix, Benjamin Legault, Nadia Ekindi, Maxime Noel-Lamy, Pavic M, et Patrick O. Richard. « Malignant Solitary Fibrous Tumour of the Kidney with an Extensive Thrombus: A Case Report and Review of the Literature ». Urology Case Reports 26 (septembre 2019): 100974. https://doi.org/10.1016/j.eucr.2019.100974.

3.      Dion, J., M. Malphettes, L. Bénéjat, F. Mégraud, A. Wargnier, D. Boutboul, L. Galicier, Pavic M  et al. « Campylobacter infection in adult patients with primary antibody deficiency ». Journal of Allergy and Clinical Immunology: In Practice 7, no 3 (2019): 1038-1041.e4. https://doi.org/10.1016/j.jaip.2018.06.014.

4.      Ellin, F., Maurer, M.J., Srour, L., Farooq, U., Jerkeman, M., Connors, J.M., Smedby, K.E., Bennani, N.N., Ansell, S.M., Slack, G.W., Cerhan, J.R., Relander, T., Feldman, A.L., Savage, K.J., 2019. Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas. Br. J. Haematol. https://doi.org/10.1111/bjh.15859

5.      Fernandes C, Ethier V , Sofia Marouan, Myrna Chababi-Atallah, et Mylène Veilleux. « Localized Ulcerative Nodular Amyloidosis Presenting as Ulcerative Panniculitis, an Unusual Clinical Manifestation: A Case Report ». SAGE Open Medical Case Reports 7 (2019): https://doi.org/10.1177/2050313X19890755.

6.      Landry M, Bienz MN,  Sawan B, Rabia Temmar, Beauregard P, Chaunt F, Lavigne J, et  Knecht H. « Bone Marrow Immunohistochemistry and Flow Cytometry in the Diagnosis of Malignant Hematologic Diseases With Emphasis on Lymphomas: A Comparative Retrospective Study ». Applied Immunohistochemistry & Molecular Morphology: AIMM, 8 juillet 2019. https://doi.org/10.1097/PAI.0000000000000787.

7.      Marcotte, M.-E., F. Panet, E. Croteau, M.-A. Richard, Pavic, M., et M.-A. Levasseur. « Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture ». European Journal of Nuclear Medicine and Molecular Imaging 46, no 11 (2019): 2402‑3. https://doi.org/10.1007/s00259-019-04412-6.

8.      Maréchal, R., Fontvieille, A., Parent-Roberge, H., Fülöp, T., Riesco, E., Pavic, M., Dionne,I.J., 2019. Effect of a mixed-exercise program on physical capacity and sedentary behavior in older adults during cancer treatments. https://doi.org/10.1007/s40520-018-1097-4

9.      Mizrahi, T., Doyon, K., Dubé, E., Bonnefoy, A., Warner, M., Cloutier, S., Demers, C., Castilloux, J.-F., Rivard, G.-E., St-Louis, J., 2019. Relapse pattern and long-term outcomes in subjects with acquired haemophilia A. Haemophilia. https://doi.org/10.1111/hae.13685

10.  Mok, Tony S. K., Yi-Long Wu, Iveta Kudaba, Dariusz M. Kowalski, Byoung Chul Cho, Hande Z. Turna, Gilberto Castro, De Angelis Flavia, Speranza Giovana et al. 2019. « Pembrolizumab versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (KEYNOTE-042): A Randomised, Open-Label, Controlled, Phase 3 Trial ». Lancet (London, England) 393 (10183): 1819‑30. https://doi.org/10.1016/S0140-6736(18)32409-7.

11.  Owonikoko, Taofeek K., Huifeng Niu, Kristiaan Nackaerts, Tibor Csoszi, Gyula Ostoros, Zsuzsanna Mark, Christina Baik, Speranza Giovana et al. « Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses ». Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 23 octobre 2019. https://doi.org/10.1016/j.jtho.2019.10.013.

12.  Poder, T.G., Carrier, N., McFadden, N., Pavic, M., 2019. Health utilities in cancer patients: A study protocol for a prospective, longitudinal cohort using online survey. Medicine 98, e14647. https://doi.org/10.1097/MD.0000000000014647

13.  Roux, S., Massicotte, M.-H., Huot Daneault, A., Brazeau-Lamontagne, L., Dufresne, J., 2019. Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review. Bone 120, 482–486. https://doi.org/10.1016/j.bone.2018.12.012

14.  Seve, P., Y. Jamilloux, M. Gerfaud-Valentin, T. El-Jammal, et Pavic, M. « Should we look for neoplasia in a patient with unexplained granulomatosis? » Revue de Medecine Interne 40, no 8 (2019): 487‑90. https://doi.org/10.1016/j.revmed.2019.05.006.

15.  Soldera, S.V., J. Kavanagh, M. Pintilie, N.B. Leighl, M. de Perrot, J. Cho, A. Hope, R. Feld, et P.A. Bradbury. « Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma ». Oncologist 24, no 7 (2019): e510‑17. https://doi.org/10.1634/theoncologist.2018-0501.

2018

  • Alexandra Desnoyers, Michel Pavic, Paul-Michel Houle, Jean-Francois Castilloux, Patrice Beauregard, Line Delisle, Richard Le Blanc, Jean Dufresne, Josie-Anne Boisjoly, Vincent Ethier Retrospective Study of High Hemoglobin Levels in 56 Young Adults. Journal of hematology Volume 7, 2;  43-50
  • Gandhi, Leena, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, et al. « Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer ». The New England Journal of Medicine 378, no 22 (31 2018): 2078‑92. https://doi.org/10.1056/NEJMoa1801005.
  • Le Blanc R 2018 "Bayesian analysis on a noncentral Fisher-Student’s hypersphere", The American Statistician http://doi.org/10.1080/00031305.2017.1377111

2017

Brunet, V., Marouan, S., Routy, J.-P., Hashem, M.A., Bernier, V., Simard, R., Petrella, T., Lamarre, L., Théorêt, G., Carrier, C., Knecht, H., Fleury, I., Pavic, M., 2017. Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec: A retrospective study of 29 case reports. Medicine. 96, e5985. 

Charlier, C., Perrodeau, É., Leclercq, A., Cazenave, B., Pilmis, B., Henry, B., Lopes, A., Maury, M.M., Moura, A., Goffinet, F., Dieye, H.B., Thouvenot, P., Ungeheuer, M.-N., Tourdjman, M., Goulet, V., de Valk, H., Lortholary, O., Ravaud, P., Lecuit, M., MONALISA study group [Pavic, M.], 2017. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet. Infect. Dis. 17, 510–519. 

Éthier, V., Gupta, V., Busque, L., 2017. The authors’ reply. Am. J. Clin. Pathol. 147, 439–440. 

Knecht, H., Johnson, N.A., Haliotis, T., Lichtensztejn, D., Mai, S., (2017). Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells. Lab. Invest. 97(7):772‑781. URL: www.ncbi.nlm.nih.gov/pubmed/28436953

Knecht, H., Mai, S., 2017. LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin’s Lymphoma. Viruses 9, art. no. 164. 

Nikonova, A., Esfahani, K., Chausse, G., Probst, S., Petrogiannis-Haliotis, T., Knecht, H., Gyger, G., n.d. Erdheim-Chester Disease: The Importance of Information Integration. Case Rep. Oncol. 10(2):613–619. URL: http://www.ncbi.nlm.nih.gov/pubmed/28868020

Poder, T.G., Boileau, J.-C., Lafrenière, R., Thibault, L., Carrier, N., de Grandmont, M.-J., Beauregard, P., 2017. Quantitative assessment of haemolysis secondary to modern infusion pumps. Vox Sang. 112, 201–209. 

Szczurek, A., Klewes, L., Xing, J., Gourram, A., Birk, U., Knecht, H., Dobrucki, J.W., Mai, S., Cremer, C., 2017. Imaging chromatin nanostructure with binding-activated localization microscopy based on DNA structure fluctuations. Nucleic Acids Res. 45, e56. 

[1] Les publications issues d’une collaboration inter-services sont répertoriées dans chacun des services impliqués.

[2] La liste des auteurs a parfois été raccourcie par […] ou et al. par soucis d’espace.

2016

Barba, T., Boileau, J.-C., Pasquet, F., Hot, A.,Pavic, M., 2016. [Inherited primitive and secondary polycythemia]. La Rev. Med. interne 37, 460–465.        

Bertinchamp, R., Gérard, L., Boutboul, D., Malphettes, M., Fieschi, C., Oksenhendler, E., DEFI study group, 2016 [Pavic, M.]. Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency. J. allergy Clin. Immunol. Pract. 4, 1147–1157.     

Busque, L., Porwit, A., Day, R., Olney, H.J., Leber, B., Ethier, V., Sirhan, S., Foltz, L., Prchal, J., Kamel-Reid, S., Karsan, A., Gupta, V., 2016. Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations  of the Canadian Mpn Group. Am. J. Clin. Pathol. 146, 408–422.            

Desnoyers, A., Riesco, E., Fulop, T., Pavic, M., 2016. [Physical activity and cancer: Update and literature review]. La Rev. Med. interne 37, 399–405.        

Ebbo, M., Gérard, L., Carpentier, S., Vély, F., Cypowyj, S., Farnarier, C., Vince, N., Malphettes, M., Fieschi, C., Oksenhendler, E., Schleinitz, N., Vivier, E., DEFI Study Group, 2016 [Pavic, M.]. Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency. EBioMedicine 6, 222–30.         

Éthier, V., Sirhanm, S., Olney, H.J., Gupta, V., Busque, L., 2016. The 2016 WHO criteria for the diagnosis of Polycythemia Vera: benefits and potential risks. Blood 127.     

Foucaut, A.-M., Berthouze, S.E., Berthouze, S.E., Robert, B., Brunet, M., Calmels, P., Coldefy, G., Pavic, M., et al., 2016. Physical activity and cancer Reference text | Activité physique et cancer. Hematologie 22.         

Poder, T.G., Pruneau, D., Dorval, J., Thibault, L., Fisette, J.-F., Bédard, S.K., Jacques, A., Beauregard, P., 2016. Effect of warming and flow rate conditions of blood warmers on red blood cell integrity. Vox Sang. 111.

Poder, T.G., Pruneau, D., Dorval, J., Thibault, L., Fisette, J.-F., Bédard, S.K., Jacques, A., Beauregard, P., 2016. Pressure Infusion Cuff and Blood Warmer during Massive Transfusion: An Experimental Study About Hemolysis and Hypothermia. PLoS One 11, e0163429.           

Righolt, C.H., Knecht, H., Mai, S., 2016. DNA Superresolution Structure of Reed-Sternberg Cells Differs between Long-Lasting Remission Versus Relapsing Hodgkin’s Lymphoma Patients. J. Cell. Biochem. 117, 1633–1637.

Tremblay, D., Latreille, J., Bilodeau, K., Samson, A., Roy, L., L’Italien, M.-F., Mimeault, C., 2016. Improving the Transition From Oncology to Primary Care Teams: A Case for Shared Leadership. J. Oncol. Pract. 12, 1012–1019.             

Viallard, J.F., Agape, P., Barlogis, V., Cozon, G., Faure, C., Fouyssac, F., Gaud, C., Gourin, M.P., Hamidou, M., Hoarau, C., Husseini, F., Ojeda-Uribe, M., Pavic, M., Pellier, I., Perlat, A., Schleinitz, N., Slama, B., 2016. Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial. BMC Immunol. 17, 34.

[1] Les publications issues d’une collaboration inter-services sont répertoriées dans chacun des services impliqués.

[2] La liste des auteurs a parfois été raccourcie par […] ou et al. par soucis d’espace.